Lung Cancer
Volume 67, Issue 2 , Pages 232-236, February 2010

Use of a simplified geriatric evaluation in thoracic oncology

  • Tristan Cudennec

      Affiliations

    • Service de Médecine Gériatrique, CHU Ambroise Paré, Assistance Publique – Hôpitaux de Paris, UFR Médicale, Université Versailles Saint Quentin, Paris, France
  • ,
  • Thierry Gendry

      Affiliations

    • Service de Pneumologie, CHU Ambroise Paré, Assistance Publique – Hôpitaux de Paris, UFR Médicale, Université Versailles Saint Quentin, Paris, France
  • ,
  • Sylvie Labrune

      Affiliations

    • Service de Pneumologie, CHU Ambroise Paré, Assistance Publique – Hôpitaux de Paris, UFR Médicale, Université Versailles Saint Quentin, Paris, France
  • ,
  • Violaine Giraud

      Affiliations

    • Service de Pneumologie, CHU Ambroise Paré, Assistance Publique – Hôpitaux de Paris, UFR Médicale, Université Versailles Saint Quentin, Paris, France
  • ,
  • Sophie Moulias

      Affiliations

    • Service de Médecine Gériatrique, CHU Ambroise Paré, Assistance Publique – Hôpitaux de Paris, UFR Médicale, Université Versailles Saint Quentin, Paris, France
  • ,
  • Laurent Teillet

      Affiliations

    • Service de Médecine Gériatrique, CHU Ambroise Paré, Assistance Publique – Hôpitaux de Paris, UFR Médicale, Université Versailles Saint Quentin, Paris, France
  • ,
  • Thierry Chinet

      Affiliations

    • Service de Pneumologie, CHU Ambroise Paré, Assistance Publique – Hôpitaux de Paris, UFR Médicale, Université Versailles Saint Quentin, Paris, France
    • Corresponding Author InformationCorresponding author at: Service de Pneumologie, AP-HP, Hôpital Ambroise Paré, 9 Avenue Charles de Gaulle, 92104 Boulogne, France. Tel.: +33 1 49 09 58 02.

Received 3 December 2008; received in revised form 3 April 2009; accepted 6 April 2009. published online 08 May 2009.

Abstract 

Management of elderly patients with bronchial cancer should take into account specific factors linked to the patient's age, and the presence of co-morbidities. A geriatric evaluation enables us to use relevant information in the therapeutic decision-making process. However, the Comprehensive Geriatric Assessment described in the literature is tedious and time-consuming. We describe the use of a simplified geriatric evaluation (SGE), in 57 patients aged ≥75 years (mean age: 80.8 years) with thoracic cancer, before discussing therapeutic options with colleagues from various departments. This evaluation enabled us to classify the patients into four groups: group 1 consisted of patients in a good general state; group 2+ comprised patients with no more than two stabilized co-morbidities or one poorly or non-stabilized co-morbidity; group 2− comprised patients with more than two stabilized co-morbidities, or at least two poorly or non-stabilized co-morbidities; group 3 consisted of frail patients. The three patients in group 1 did not have any negative factors that could complicate their management and therefore received anti-tumor therapy. The 15 patients in group 3 were considered to have co-morbidities or functional alterations that were too advanced for them to benefit from anti-tumor therapy, and received symptomatic treatment only. Among the 39 patients in the intermediary groups 2+ and 2−, 24 underwent surgery, chemotherapy or radiotherapy (21 (87.5%) patients in group 2+ and 3 (20.0%) patients in group 2−). These data suggest that the SGE is an important aid to decision-making in the management of elderly patients with bronchial cancer.

Keywords: Geriatric evaluation, Lung cancer, Elderly patients, Geriatric oncology

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0169-5002(09)00212-8

doi:10.1016/j.lungcan.2009.04.001

Lung Cancer
Volume 67, Issue 2 , Pages 232-236, February 2010